The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology

被引:16
作者
Duchesneau, Emilie D. [1 ]
Jackson, Bradford E. [2 ]
Webster-Clark, Michael [1 ]
Lund, Jennifer L. [1 ,2 ]
Reeder-Hayes, Katherine E. [2 ,3 ]
Napoles, Anna M. [4 ]
Strassle, Paula D. [4 ]
机构
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Div Oncol, Dept Med, Chapel Hill, NC 27515 USA
[4] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, NIH, Bethesda, MD 20892 USA
关键词
METASTATIC BREAST-CANCER; PRIMARY TUMOR; SURVIVAL; SURGERY; THERAPY; WEIGHTS; BENEFIT; MODELS; TRIAL; SCORE;
D O I
10.1158/1055-9965.EPI-22-0495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Studies evaluating the effects of cancer treatments are prone to immortal time bias that, if unaddressed, can lead to treatments appearing more beneficial than they are.Methods: To demonstrate the impact of immortal time bias, we compared results across several analytic approaches (dichotomous exposure, dichotomous exposure excluding immortal time, time-varying exposure, landmark analysis, clone-censor-weight meth-od), using surgical resection among women with metastatic breast cancer as an example. All adult women diagnosed with incident metastatic breast cancer from 2013-2016 in the National Cancer Database were included. To quantify immortal time bias, we also conducted a simulation study where the "true" relationship between surgical resection and mortality was known.Results: 24,329 women (median age 61, IQR 51-71) were includ-ed, and 24% underwent surgical resection. The largest association between resection and mortality was observed when using a dichot-omized exposure [HR, 0.54; 95% confidence interval (CI), 0.51-0.57], followed by dichotomous with exclusion of immortal time (HR, 0.62; 95% CI, 0.59-0.65). Results from the time-varying exposure, land-mark, and clone-censor-weight method analyses were closer to the null (HR, 0.67-0.84). Results from the plasmode simulation found that the time-varying exposure, landmark, and clone-censor-weight method models all produced unbiased HRs (bias -0.003 to 0.016). Both standard dichotomous exposure (HR, 0.84; bias, -0.177) and dichotomous with exclusion of immortal time (HR, 0.93; bias, -0.074) produced meaningfully biased estimates. Conclusions: Researchers should use time-varying exposures with a treatment assessment window or the clone-censor-weight method when immortal time is present.Impact: Using methods that appropriately account for immortal time will improve evidence and decision-making from research using real-world data.
引用
收藏
页码:2079 / 2086
页数:8
相关论文
共 51 条
  • [41] Immortal time bias in pharmacoepidemiology
    Suissa, Samy
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (04) : 492 - 499
  • [42] Immortal time bias in observational studies of drug effects
    Suissa, Samy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (03) : 241 - 249
  • [43] Do Oscar winners live longer than less successful peers? A reanalysis of the evidence
    Sylvestre, Marie-Pierre
    Huszti, Ella
    Hanley, James A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (05) : 361 - 363
  • [44] Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011
    Thomas, Alexandra
    Khan, Seema A.
    Chrischilles, Elizabeth A.
    Schroeder, Mary C.
    [J]. JAMA SURGERY, 2016, 151 (05) : 424 - 431
  • [45] Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
    Vandenbroucke, Jan P.
    von Elm, Erik
    Altman, Douglas G.
    Gotzsche, Peter C.
    Mulrow, Cynthia D.
    Pocock, Stuart J.
    Poole, Charles
    Schlesselman, James J.
    Egger, Matthias
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) : W163 - W194
  • [46] The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
    von Elm, Erik
    Altman, Douglas G.
    Egger, Matthias
    Pocock, Stuart J.
    Gotzsche, Peter F.
    Vandenbroucke, Jan P.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) : 573 - 577
  • [47] Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer A Propensity-adjusted, Population-based SEER Trend Analysis
    Warschkow, Rene
    Guller, Ulrich
    Tarantino, Ignazio
    Cerny, Thomas
    Schmied, Bruno M.
    Thuerlimann, Beat
    Joerger, Markus
    [J]. ANNALS OF SURGERY, 2016, 263 (06) : 1188 - 1198
  • [48] THE ACCELERATED FAILURE TIME MODEL - A USEFUL ALTERNATIVE TO THE COX REGRESSION-MODEL IN SURVIVAL ANALYSIS
    WEI, LJ
    [J]. STATISTICS IN MEDICINE, 1992, 11 (14-15) : 1871 - 1879
  • [49] Target Validity and the Hierarchy of Study Designs
    Westreich, Daniel
    Edwards, Jessie K.
    Lesko, Catherine R.
    Cole, Stephen R.
    Stuart, Elizabeth A.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2019, 188 (02) : 438 - 443
  • [50] Immortal Time Bias in Observational Studies
    Yadav, Kabir
    Lewis, Roger J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 686 - 687